Mariam Oladejo
Immunotherapeutics and Biotechnology
 |
|
Biography
Mariam Oladejo completed her Bachelor of Pharmacy (BPharm) degree from Obafemi Awolowo University, Ile-Ife, Nigeria in 2016. She joined the Graduate Program in Pharmaceutical Sciences as a Doctor of Philosophy (PhD) student in August of 2019, and is presently working in the laboratory of Dr. Laurence Wood with the Department of Immunotherapeutics and Biotechnology in Abilene.
Education:
- BPharm: Obafemi Awolowo University, Ile-Ife, Nigeria, 2016
Research Interests:
Listeria monocytogenes-based immunotherapy, targeted cancer therapy, cancer immunology.
Publications:
- Oladejo M, Nguyen HM, Seah H, Datta A, Wood LM. Tumoral CD105 promotes immunosuppression, metastasis, and angiogenesis in renal cell carcinoma. Cancer Immunol Immunother. 2023 Jun; 72(6):1633-1646. Epub 2022 Dec 31.
- Nguyen HM, Gaikwad S, Oladejo M, Agrawal MY, Srivastava SK, Wood LM. Interferon stimulated gene 15 (ISG15) in cancer: An update. Cancer Lett. 2023 Mar 1; 556:216080. Epub 2023 Feb 1.
- Nguyen HM, Gaikwad S, Oladejo M, Paulishak W, Wood LM. Targeting Ubiquitin-like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer. Cancers (Basel). 2023 Feb 15; 15(4):1237.
- Oladejo M, Paulishak W, Wood L. Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines. Semin Cancer Biol. 2023 Jan; 88:81-95. Epub 2022 Dec 13.
- Nguyen HM, Paulishak W, Oladejo M, Wood L. Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches. Breast Cancer. 2023 Mar; 30(2):167-186. Epub Nov 18.
- Oladejo M, Nguyen HM, Silwal A, Reese B, Paulishak W, Markiewski MM, Wood LM. Listeria-based immunotherapy directed against CD105 exerts antiangiogenic and anti-tumor efficacy in renal cell carcinoma. Front Immunol. 2022 Nov 11; 13:1038807.
- Oladejo M, Paterson Y, Wood LM. Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies. Front Immunol. 2021 Apr 14; 12:642316.
Presentations:
- Mariam Oladejo and Laurence Wood. "Listeria-based immunotherapy sculpts CD8+ T cell response in the tumor microenvironment to control renal cell carcinoma". Society for Immunotherapy of Cancer (SITC), Boston, MA; November 2022.
- Mariam Oladejo and Laurence M. Wood. "A Listeria-Based Vaccine Directed against CD 105 in Renal Cell Carcinoma". 19th Annual Research Days, TTUHSC Jerry H Hodge School of Pharmacy, Office of Sciences in Amarillo, event at Lubbock, TX; June 2022.
- Mariam Oladejo and Laurence M Wood. "Tumoral Endoglin (CD105) Regulates the Tumor Microenvironment, Tumorigenicity, and Therapeutic Response in Renal Cell Carcinoma". Society for Immunotherapy of Cancer (SITC) 2022 Tumor Immune Microenvironment: A Holistic Approach, San Diego, CA; April 2022.
- Mariam Oladejo and Laurence. M. Wood. "Tumoral Endoglin (CD105) Regulates the Tumor Microenvironment, Tumorigenicity and Therapeutic Response in Renal Cell Carcinoma". Student Research Week, TTUHSC Graduate School of Biomedical Sciences, Lubbock; March 2022.
- Mariam Oladejo, Min Xie, Hannah Seah , Britney Reese and Laurence. M. Wood. "Characterization and Therapeutic Targeting of CD105 in Renal Cell Carcinoma". Research Days, TTUHSC Jerry H Hodge School of Pharmacy, Amarillo (virtual); June 2021.
Seminars:
- 03/15/2023 "CD105 and ISG16 as Modulators of Immunotherapeutic Response in Renal Cell Carcinoma" [Dissertation Defense, presentation counted as Seminar credit]
- 10/15/2021 "A Multipotent Listeria-Based Vaccine against EBV-Associated Colorectal Cancer" [Oral Qualifying Exam, public presentation counted as Seminar credit]
- 04/16/2021 "Characterization and Therapeutic Targeting of CD105 in Renal Cell Carcinoma (RCC)"
Awards/Scholarships:
- Graduate Research Grant, The Honor Society of Phi Kappa Phi (International), February 2023.
- Love of Learning Award, The Honor Society of Phi Kappa Phi (International), September 2022.
- Howard Hughes Medical Institute (HHMI) Scholarship, 100% reduction of registration fees, Jackson Lab's, Farmington, Connecticut (virtual); August 2022.
- Travel Grant Award, Cayman Chemical Co., Society for Immunotherapy of Cancer (SITC) 2022 Tumor Immune Microenvironment: A Holistic Approach, San Diego, CA; April 2022.
- Mary Lou Clements-Mann Endowed Scholarship, TTUHSC Graduate School of Biomedical Sciences (GSBS), Fall 2021.
Memberships:
- The Honor Society of Phi Kappa Phi (International), TTUHSC Chapter, 2022-present.
- Society for Immunotherapy of Cancer (SITC), 2022-present.
- Immunotherapeutics and Biotechnology Graduate Student Association (IBGSA), TTUHSC, 2019-present.